Opinion: Toot Your Horn

Why (and how) scientists should advocate for their research with journalists and policymakers

Written byJordan Gaines Lewis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

© ISTOCK.COM/BPLANETLong gone are the days of the lone investigator who discovered a new scientific truth, published the finding in a journal, and continued doing bench research. Nowadays, scientists have to wear any number of different hats: experimenter, data analyst, teacher, mentor, negotiator, financial planner, writer, boss, philosopher, and speaker.

Meet with your legislators. You can schedule a meeting in their Washington offices or in your home district; going with a small group of colleagues is always best. Many large scientific societies host their own advocacy days for scientists to converge on the capital and meet with their representatives in small, region-specific groups. These societies often provide resources and a specific message, or ask scientists to share their research during the meetings. If you are having difficulty scheduling a meeting, local town halls are another good place to meet your legislator face-to-face.

Write, call, tweet, Facebook. Legislative representatives have easily accessible contact information on their websites. When certain science or research funding–related items are up for a vote, many scientific societies often craft form letters ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

November 2016

Nimble Neurons

The remarkable adaptability of the nervous system

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies